press release

Dec. 21, 2021, 4:05 p.m. EST

Gilead Sciences to Present at Upcoming Investor Conference

FOSTER CITY, Calif., (BUSINESS WIRE) -- Gilead Sciences, Inc. /zigman2/quotes/210293917/composite GILD -0.05% announced today that its executives will be speaking at the following investor conference:

J.P. Morgan Healthcare Conference and Q&A Breakout on Monday, January 10 beginning at 11:15 a.m. Eastern Time

The live webcast can be accessed at the company’s investors page at . The replay will be available for at least 30 days following the presentation.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on

SOURCE: Gilead Sciences, Inc.

Jacquie Ross, Investors


Is there a problem with this press release? Contact the source provider Comtex at You can also contact MarketWatch Customer Service via our Customer Center.

Copyright Business Wire 2021

US : U.S.: Nasdaq
$ 64.44
-0.03 -0.05%
Volume: 2.29M
May 27, 2022 12:15p
P/E Ratio
Dividend Yield
Market Cap
$80.87 billion
Rev. per Employee


Partner Center

Link to MarketWatch's Slice.